Leon Poltawski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leon Poltawski has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Tim Watson
School of Health and Social Work, University of Hertfordshire, Hatfield AL10 9AB, UK
2 shared publications Amy Todd
Division of Physiotherapy, University of Hertfordshire, UK
1 shared publicationAndrew Lees
Reta Lila Weston Institute of Neurological Studies, University College London, London, UK
1 shared publicationCherry Ann James
Department of Neurology, University College London, London, UK
1 shared publicationHazel Edwards
Division of Radiography, University of Hertfordshire, UK
1 shared publication
Latest Publications
- 15 January 2009
- Published by Wiley in Movement Disorders
- Vol. 24 (1) , 115-118
Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study
Apomorphine hydrochloride is a dopamine agonist used in the treatment of advanced Parkinson's disease. Its administration by subcutaneous infusions is associated with the development of nodules that may interfere with absorption of the drug. This pilot study assessed the effectiveness of ultrasound (US) in the treatment of these nodules. Twelve participants were randomly assigned to receive a course of real or sham US on an area judged unsuitable for infusion. Following treatment, no significant change was observed in measures of tissue hardness and tenderness. However, 5 of 6 participants receiving real US rated the treated area suitable for infusion compared with the 1 of 6 receiving sham US. Sonographic appearance improved in both groups, but more substantially in the real US group. Power calculations suggest a total sample size of 30 would be required to establish statistical significance. A full‐scale study of the effectiveness of therapeutic US in the treatment of apomorphine nodules is warranted. © 2008 Movement Disorder Society
- 15 January 2009
- Published by Wiley in Movement Disorders
- Vol. 24 (1) , 115-118
Ultrasound treatment of cutaneous side‐effects of infused apomorphine: A randomized controlled pilot study
Apomorphine hydrochloride is a dopamine agonist used in the treatment of advanced Parkinson's disease. Its administration by subcutaneous infusions is associated with the development of nodules that may interfere with absorption of the drug. This pilot study assessed the effectiveness of ultrasound (US) in the treatment of these nodules. Twelve participants were randomly assigned to receive a course of real or sham US on an area judged unsuitable for infusion. Following treatment, no significant change was observed in measures of tissue hardness and tenderness. However, 5 of 6 participants receiving real US rated the treated area suitable for infusion compared with the 1 of 6 receiving sham US. Sonographic appearance improved in both groups, but more substantially in the real US group. Power calculations suggest a total sample size of 30 would be required to establish statistical significance. A full‐scale study of the effectiveness of therapeutic US in the treatment of apomorphine nodules is warranted. © 2008 Movement Disorder Society
- 1 January 2007
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 33 (1) , 120-128
Relative transmissivity of ultrasound coupling agents commonly used by therapists in the UK
- 1 January 2007
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 33 (1) , 120-128
Relative transmissivity of ultrasound coupling agents commonly used by therapists in the UK